Efficacy and Safety of Rovalpituzumab Tesirine Compared With Topotecan as Second-Line Therapy in DLL3-High SCLC: Results From the Phase 3 TAHOE Study von Blackhall, Fiona, Jao, Kevin, Greillier, Laurent, Cho, Byoung Chul, Penkov, Konstantin, Reguart, Noemi, Majem, Margarita, Nackaerts, Kristiaan, Syrigos, Konstantinos, Hansen, Karin, Schuette, Wolfgang, Cetnar, Jeremy, Cappuzzo, Federico, Okamoto, Isamu, Erman, Mustafa, Langer, Seppo W., Kato, Terufumi, Groen, Harry, Sun, Zhaowen, Luo, Yan, Tanwani, Poonam, Caffrey, Laura, Komarnitsky, Philip, Reinmuth, Niels

Volltext

Efficacy and Safety of Rovalpituzumab Tesirine Compared With Topotecan as Second-Line Therapy in DLL3-High SCLC: Results From the Phase 3 TAHOE Study von Blackhall, Fiona, Jao, Kevin, Greillier, Laurent, Cho, Byoung Chul, Penkov, Konstantin, Reguart, Noemi, Majem, Margarita, Nackaerts, Kristiaan, Syrigos, Konstantinos, Hansen, Karin, Schuette, Wolfgang, Cetnar, Jeremy, Cappuzzo, Federico, Okamoto, Isamu, Erman, Mustafa, Langer, Seppo W, Kato, Terufumi, Groen, Harry, Sun, Zhaowen, Luo, Yan, Tanwani, Poonam, Caffrey, Laura, Komarnitsky, Philip, Reinmuth, Niels

Volltext

A Phase 1b Study Evaluating the Safety and Efficacy of Venetoclax in Combination with Azacitidine in Treatment-Naïve Patients with Higher-Risk Myelodysplastic Syndrome von Wei, Andrew H., Garcia, Jacqueline S, Borate, Uma, Fong, Chun Yew, Baer, Maria R., Nolte, Florian, Peterlin, Pierre, Jurcic, Joseph G., Garcia-Manero, Guillermo, Hong, Wan-Jen, Platzbecker, Uwe, Odenike, Olatoyosi, Dunbar, Martin, Zhou, Ying, Harb, Jason, Tanwani, Poonam, Wolff, Johannes E., Jacoby, Meagan

Volltext

MDS-141: The Prognostic Impact of Cytogenetic Scores in Patients with Higher-Risk Myelodysplastic Syndrome Treated with Venetoclax and Azacitidine in a Phase 1 Study von Garcia, Jacqueline S, Wei, Andrew H, Borate, Uma, Fong, Chun Yew, Baer, Maria R, Nolte, Florian, Peterlin, Pierre, Jurcic, Joseph, Jacoby, Meagan, Hong, Wan-Jen, Platzbecker, Uwe, Odenike, Olatoyosi, Cunningham, Ilona, Zhou, Ying, Dunbar, Martin, Harb, Jason G, Popovic, Relja, Tanwani, Poonam, Gopalakrishnan, Sathej, Wolff, Johannes, Garcia-Manero, Guillermo

Volltext

Efficacy and Safety of Rovalpituzumab Tesirine Compared With Topotecan as Second-Line Therapy in DLL3-High SCLC : Results From the Phase 3 TAHOE Study von Blackhall, Fiona, Jao, Kevin, Greillier, Laurent, Cho, Byoung Chul, Penkov, Konstantin, Reguart, Noemi, Majem, Margarita, Nackaerts, Kristiaan, Syrigos, Konstantinos, Hansen, Karin, Schuette, Wolfgang, Cetnar, Jeremy, Cappuzzo, Federico, Okamoto, Isamu, Erman, Mustafa, Langer, Seppo W, Kato, Terufumi, Groen, Harry, Sun, Zhaowen, Luo, Yan, Tanwani, Poonam, Caffrey, Laura, Komarnitsky, Philip, Reinmuth, Niels

Volltext bestellen